🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase 1b/2 multi-center study to assess the safety, tolerab...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2020-06-22
Trial ID
NCT04492033
Treatments Being Tested
The aim of this study was to collect existing information from the medical ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-12-16
Trial ID
NCT07644351
The aim of this study was to evaluate the real-world treatment patterns, he...
Status
Completed
Location
Novartis
Start Date
2024-02-27
Trial ID
NCT07188428
The objective of this Phase II study is to assess the potential of ascimini...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-02-18
Trial ID
NCT06514534
Treatments Being Tested
The purpose of this study is to evaluate the intracranial response rate of ...
Status
Recruiting
Location
Duke University
Start Date
2026-07-07
Trial ID
NCT07136428
Treatments Being Tested
The aim of this study is to support development of asciminib in the pediatr...
Status
Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2026-04-28
Trial ID
NCT07354074
Treatments Being Tested
The Drugs Controller General of India (DCGI) has granted approval for Ascim...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-11-28
Trial ID
NCT06427811
Treatments Being Tested
The purpose of this open-label, dose escalation-dose expansion, Phase 1 cli...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2017-09-18
Trial ID
NCT03292783
Treatments Being Tested
The main purpose of this study is to evaluate the effect of varying degrees...
Status
Completed
Location
University of Miami / Clinical Research Services, Inc.
Start Date
2016-05-03
Trial ID
NCT02857868
Treatments Being Tested
The goal of this observational study is to evaluate the efficacy and tolera...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07640750